Literature DB >> 8818691

Primary sarcomas of the lung: a clinicopathological and immunohistochemical study of 14 cases.

R L Attanoos1, M A Appleton, A R Gibbs.   

Abstract

The clinicopathological features and immunohistochemical findings in 14 primary sarcomas of the lung collected over a 30-year-period are presented. This represents one sarcoma per 550 bronchogenic carcinomas undergoing resection in this centre. The study group comprised six leiomyosarcomas, five malignant peripheral nerve sheath tumours, two haemangiopericytomas and one epithelioid haemangioendothelioma. The majority of cases occurred in men (nine males: five females), with mean age at presentation of 54 years for men and 47 years for women. All leiomyosarcomas were seen in men, whereas malignant peripheral nerve sheath tumours showed no particular sex preponderance. Leiomyosarcomas were larger tumours than malignant peripheral nerve sheath tumours, mean tumour diameter 15 cm (range 10-25 cm) compared to 9.5 cm (7-15 cm), respectively. All leiomyosarcomas were situated intraparenchymally whereas two of the five malignant peripheral nerve sheath tumours were endobronchial in site. Extrathoracic metastates were seen at death in two of the six leiomyosarcomas but not in any of the malignant peripheral nerve sheath tumours. Overall survival was 28 months although for the leiomyosarcoma/malignant peripheral nerve sheath tumour group alone survival was 8 months. Tumour grading appeared to be a more useful prognostic factor than tumour site (endobronchial/parenchymal) or tumour size. Haemangiopericytoma and epithelioid haemangioendothelioma were associated with a more favourable prognosis.

Entities:  

Mesh:

Year:  1996        PMID: 8818691     DOI: 10.1046/j.1365-2559.1996.d01-481.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  8 in total

1.  Primary pulmonary myxoid sarcomas with EWSR1-CREB1 translocation might originate from primitive peribronchial mesenchymal cells undergoing (myo)fibroblastic differentiation.

Authors:  Yoon Kyung Jeon; Kyung Chul Moon; Sung-Hye Park; Doo Hyun Chung
Journal:  Virchows Arch       Date:  2014-08-19       Impact factor: 4.064

2.  An uncommon histopathological diagnosis.

Authors:  Hannelore Bode; Raf Sciot; Emilie Werbrouck; Eric Geusens; Christophe M Deroose; Kristiaan Nackaerts
Journal:  Breathe (Sheff)       Date:  2018-12

3.  A case of primary pulmonary leiomyosarcoma.

Authors:  Yoshiki Yata; Yuji Ito; Kimikazu Iwamoto; Akifumi Kumazawa; Tadashi Yosihara; Toshio Kato; Mitsushi Okazawa
Journal:  Respir Med Case Rep       Date:  2019-05-27

4.  Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion: a case report and review of the literature.

Authors:  Zhenwei Chen; Yihui Yang; Rongming Chen; Chi Sing Ng; Hongqi Shi
Journal:  Diagn Pathol       Date:  2020-02-10       Impact factor: 2.644

5.  Adjuvant chemotherapy is not a decisive factor in improving the overall survival of pulmonary sarcoma: A population-based study.

Authors:  Long Liang; Zixuan Liu; Changhui Wang; Shuanshuan Xie
Journal:  Front Oncol       Date:  2022-08-25       Impact factor: 5.738

6.  Primary pulmonary leiomyosarcoma with invasion of the pulmonary vein-A case report.

Authors:  Elizabeth M Colwell; Mohamed F Algahim; Arjun Rao; Mario G Gasparri
Journal:  Int J Surg Case Rep       Date:  2015-12-23

7.  Endobronchial Smooth Muscle Tumors: A Series of Five Cases Highlighting Pitfalls in Diagnosis.

Authors:  Tripti Nakra; Aanchal Kakkar; Shipra Agarwal; Karan Madan; Suresh C Sharma; Deepali Jain
Journal:  J Pathol Transl Med       Date:  2018-07-11

8.  Outcomes of surgically managed primary lung sarcomas: a National Cancer Database analysis.

Authors:  Andrew X Li; Benjamin J Resio; Maureen E Canavan; Marianna Papageorge; Daniel J Boffa; Justin D Blasberg
Journal:  J Thorac Dis       Date:  2021-06       Impact factor: 2.895

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.